Scilex Holding (SCLXW) Treasury Shares (2023 - 2026)
Scilex Holding (SCLXW) recorded quarterly Treasury Shares of $76.9 million in Q1 2026, little changed quarter-over-quarter from $76.9 million in Q4 2025, and little changed on a YoY basis from $76.9 million in Q1 2025.
Scilex Holding (SCLXW) Treasury Shares (2023 - 2026) Analysis & Trends
Scilex Holding's Treasury Shares history runs 4 years deep, the most recent figure standing at $76.9 million for Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $76.9 million; the TTM figure through Mar 2026 stood at $76.9 million (changed 0.0% YoY), while the FY2025 annual figure was $76.9 million, down 15.03% from the prior year.
- Treasury Shares was $76.9 million for Q1 2026 at Scilex Holding, roughly flat from $76.9 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $60.1 million in Q3 2023 to a low of $1458.0 in Q1 2025.
- Historically, Treasury Shares has averaged $16.9 million across 4 years, with a median of $1.5 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares changed 0.0% in 2024, then declined 15.03% in 2025.
- A 4-year view of Treasury Shares shows it stood at $90.5 million in 2023, then changed by 0.0% to $90.5 million in 2024, then slipped by 15.03% to $76.9 million in 2025, then changed by 0.0% to $76.9 million in 2026.
- The last three Treasury Shares figures came in at $76.9 million (Q1 2026), $76.9 million (Q4 2025), and $76.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 3.01 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 76.26 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 77.08 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 881.00 Mn |
| 10 | Scilex Holding | - | - | 4.15 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 76.92 Mn |
| Mar 31, 2026 | 76.92 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Mar 31, 2025 | 1,458.00 |
| Mar 31, 2025 | 76.92 Mn |
| Mar 31, 2025 | 76.92 Mn |
| Mar 31, 2025 | 1,458.00 |